6 results  1 of 1 

1 Current Diagnosis and Management of Hypersensitivity Pneumonitis
Paolo Maria Leone, Luca Richeldi
Tuberc Respir Dis.2020;83(2):122-131.   Published online 2020 March 10     DOI: http://dx.doi.org/10.4046/trd.2020.0012
      
2 Pharmacological treatment of pulmonary fibrosis
Won-Il Choi
J Korean Med Assoc.2020;63(1):47-55.   Published online 2020 January 17     DOI: http://dx.doi.org/10.5124/jkma.2020.63.1.47
   
3 Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
Manoj Reddy, Lyle Fonseca, Shashank Gowda, Basavraj Chougule, Aarya Hari, Satish Totey
Int J Stem Cells.2016;9(2):192-206.   Published online 2016 November 30     DOI: http://dx.doi.org/10.15283/ijsc16041
      
4 Cytotoxicities and Anti-Fibrotic Effects of Pirfenidone and Mitomycin C on Human Fibroblasts
Kyoung Soo Park, Sa Min Hong, Yoko Iizuka, Chan Yun Kim, Gong Je Seong
J Korean Ophthalmol Soc.2014;55(7):1077-1083.   Published online 2014 July 15     DOI: http://dx.doi.org/10.3341/jkos.2014.55.7.1077
      
5 Interstitial Lung Disease
Man Pyo Chung
Tuberc Respir Dis.2011;71(3):163-171.   Published online 2011 September 30     DOI: http://dx.doi.org/10.4046/trd.2011.71.3.163
      
6 Pirfenidone Suppressed the Development of Glomerulosclerosis in the FGS/Kist mouse
Ho Sun Park, Lihua Bao, Yong Jin Kim, In Ho Cho, Chul Ho Lee, Byung Hwa Hyun, SB Margolin, Yong Hoon Park
J Korean Med Sci.2003;18(4):527-533.   Published online 2009 April 22     DOI: http://dx.doi.org/10.3346/jkms.2003.18.4.527
      

 1 of 1